Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (296)
- COVID-19 (160)
- Compliance and enforcement (106)
- Safety monitoring and information (100)
- Legislation (81)
- Vaping hub (59)
- Manufacturing (58)
- Import and export (42)
- Labelling and packaging (41)
- Medicinal cannabis hub (29)
- Scheduling (national classification system) (24)
- Sunscreens (20)
- Weight loss products (18)
- Peptide products (11)
- Shortages and supply disruptions (10)
- Committees and advisory bodies (8)
- Cosmetics (6)
- Clinical trials (5)
- Unique Device Identification (UDI) hub (5)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1213 result(s) found, displaying 226 to 250
-
News articlesListed medicine compliance review reports database March 2025 update
-
News articlesYour participation in this online activity will help us create a more user-friendly website that works better for everyone.
-
Regulatory decision noticesThis instrument is made under subsection 7C(1) of the Therapeutic Goods Act 1989.
-
News articlesThe updated plan emphasises solidifying our collaborative processes, aligning expectations with industry, and improving our communication strategies.
-
Media releasesThe Therapeutic Goods Administration (TGA) has seized more than 5,000 vapes, 7,000 nicotine pouches and other products across two locations in Sydney’s western suburb of Penrith.
-
Safety updatesMore prominent warnings are being added to the Product Information (PI) and Consumer Medicine Information (CMI) for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects
-
Safety updatesThere may be an increased risk of neurodevelopmental disorders in children born to men who have taken sodium valproate in the 3 months before conception.
-
News articlesFollowing a request from the sponsor to reconsider their decision, the TGA has confirmed the initial decision to not register the medicine on the basis that the safety and efficacy of the medicine were not satisfactorily established.
-
Regulatory decision noticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025, which commenced on 1 March 2025
-
Regulatory decision noticesThis instrument is made under Schedule 5A to the Therapeutic Goods Regulations 1990 and Schedule 4 to the Therapeutic Goods (Medical Devices) Regulations 2002.
-
News articlesFrom 1 March 2025, sponsors of vaping goods will be able to use a new online form of the sponsor notice.
-
News articlesWe are updating information for nitrosamine impurities and other nitroso-structure impurities in medicines including acceptable intakes (AI)
-
News articlesThe TGA has released a literature review of certain active ingredients used in sunscreens.
-
BlogAustralians who use tanning products containing ‘melanotan’ are at risk of serious health problems.
-
News articlesYour feedback is essential to shaping a user-friendly website that works better for everyone.
-
Media releasesWe have issued a combined total of $396,000 in infringement notices to 20 Melbourne retail businesses for the alleged unlawful supply of vaping goods.
-
Safety updatesAdditional safety information is being added to all montelukast products to strengthen and highlight existing warnings about serious neuropsychiatric events.
-
Regulatory decision noticesThis instrument is made under subsections 19(5AA), 32CM(1A) and 41HC(1A) of the Therapeutic Goods Act 1989.
-
Therapeutic Goods (Special Access Scheme - Application and Notification Forms) Approval (No. 2) 2024
Regulatory decision noticesThis instrument is made under the Therapeutic Goods Regulations 1990, the Therapeutic Goods (Medical Devices) Regulations 2002 and the Therapeutic Goods Act 1989. -
Media releasesThe defendant faces a maximum penalty of 12 months’ imprisonment and/or a fine of up to $222,000 for each charge.
-
News articlesRecall reforms program update and preview of the PRAC Version 1.0.
-
Media releasesWe have issued infringement notices totalling $37,560 for the alleged unlawful possession of a commercial quantity of vaping goods.
-
Safety updatesTCMs sold in Australia are carefully regulated to ensure safety and quality.
-
Media releasesThe TGA and cooperating agencies have seized a large volume of alleged illicit vapes, tobacco and other substances in coordinated operations across Australia.
-
News articlesFind out about new requirements for labels of injectable electrolyte medicines and updates to guidance for medicine sponsors.